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Background. The impact of healthcare personnel hand contamination in multidrug-resistant organism (MDRO) transmission 
is important and well studied; however, the role of patient hand contamination needs to be characterized further.
Methods. Patients from 2 hospitals in southeast Michigan were recruited within 24 hours of arrival to their room and fol-
lowed prospectively using microbial surveillance of nares, dominant hand, and 6 high-touch environmental surfaces. Sampling was 
performed on admission, days 3 and 7, and weekly until discharge. Paired samples of methicillin-resistant Staphylococcus aureus 
(MRSA) isolated from the patients’ hand and room surfaces were evaluated for relatedness using pulsed-field gel electrophoresis and 
staphylococcal cassette chromosome mec, and Panton-Valentine leukocidin typing.
Results. A total of 399 patients (mean age, 60.8 years; 49% male) were enrolled and followed for 710 visits. Fourteen percent 
(n = 56/399) of patients were colonized with an MDRO at baseline; 10% (40/399) had an MDRO on their hands. Twenty-nine per-
cent of rooms harbored an MDRO. Six percent (14/225 patients with at least 2 visits) newly acquired an MDRO on their hands 
during their stay. New MDRO acquisition in patients occurred at a rate of 24.6/1000 patient-days, and in rooms at a rate of 58.6/1000 
patient-days. Typing demonstrated a high correlation between MRSA on patient hands and room surfaces.
Conclusions. Our data suggest that patient hand contamination with MDROs is common and correlates with contamination 
on high-touch room surfaces. Patient hand hygiene protocols should be considered to reduce transmission of pathogens and health-
care-associated infections.
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Healthcare-associated infections are common, costly, and 
 potentially lethal [1]. Appropriate hand hygiene for healthcare 
personnel (HCP) is widely recognized as an important approach 
for preventing infections in hospitalized patients [2, 3]. However, 
the importance of patient hand hygiene has been recognized only 
recently [4–7]. Early evidence suggests that this is a missed op-
portunity for infection reduction and prevention [7]. For example, 
in a US study of 100 hospitalized patients, 39% of patients’ hands 
were contaminated with pathogens at ≥48 hours after admission 
[6]. Another recent study from post–acute care facilities reported 
that 1 in 4 recently hospitalized patients had at least 1 multi-
drug-resistant organism (MDRO) on their hands, suggesting that 
patient hand contamination with MDROs is common [7].
High-touch surfaces in patient rooms, such as bed con-
trols, call buttons, and bedside tray tables, represent a criti-
cally important MDRO reservoir [8, 9]. MDROs, including 
vancomycin-resistant enterococci (VRE), methicillin-resis-
tant Staphylococcus aureus (MRSA), and resistant gram-neg-
ative bacilli (RGNB), are frequently shed by patients and staff, 
whereupon they contaminate surfaces for days, increasing the 
risk of acquisition by other patients, visitors, and hospital staff 
that come in contact with these surfaces [9–13].
Compared to other anatomic sites, patients’ hands are likely 
to come in contact with high-touch surfaces, HCP, visitors, and 
other patients, increasing the risk of pathogen transmission. 
Therefore, we sought to characterize MDRO contamination on 
patients’ hands and the high-touch surfaces in their rooms in 
hospital settings. The main objectives were to determine (1) the 
prevalence of MDROs on patients’ hands and in their rooms 
within the first 24 hours of room arrival; (2) the rate of new ac-
quisition of MDROs on patients’ hands and on the high-touch 
surfaces in their rooms; and (3) the similarity between patients’ 
hand contamination and high-touch room surface contam-
ination. This information is necessary for the development, 
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evaluation, and implementation of effective patient hand hy-
giene programs in hospitals.
METHODS
Study Population and Design
This study, conducted between February and July 2017, was an 
observational, prospective cohort study targeting newly admitted 
hospitalized patients (within 24 hours of arrival to their room). 
General medicine patients at 2 hospitals in southeast Michigan 
were enrolled and followed prospectively to evaluate baseline 
colonization, high-touch surface contamination, and new acqui-
sition of MDROs. The study was approved by the institutional 
review boards at both institutions. Informed consent to collect 
surveillance samples and patient-specific data were obtained 
from each patient or their durable power of attorney.
The inclusion criteria included any patient: (1) newly admit-
ted to participating hospital units—that is, general medicine 
floors (within 24 hours of admission to their room); and (2) 
at least 18 years of age. Exclusion criteria included any patient 
(1) under observation status, generally after a procedure; (2) 
transferred from another hospital; (3) with cystic fibrosis (due 
to their high likelihood of MDRO colonization); (4) receiving 
end-of-life care; (5) non-English speaking; or (6) transferred 
from an intensive care unit. If an enrolled patient was moved 
to a new room on a nonparticipating floor, he or she was dis-
charged from the study.
Data Collection
Chart reviews were conducted and data collection sheets com-
pleted by trained research staff at each study visit on admis-
sion, hospital days 3 and 7, and weekly thereafter. A visit was 
defined as a patient interaction where clinical data and cultures 
from the patient and the patient’s room were collected. Baseline 
demographic data were obtained from the patient’s admis-
sion documentation, including age, sex, height, weight, race, 
admitting location, history of MDROs, admission diagnosis, 
Charlson comorbidity score [14], and dependence in activi-
ties of daily living (ADL) score [15, 16]. In addition to medi-
cal records, patient history of MDRO presence was obtained 
from clinical laboratory results within the past 90 days. Clinical 
data collected at each visit included diagnostic testing results 
(urine, sputum, blood, and wound cultures obtained during 
hospitalization), presence of an infection, antibiotic use, device 
use, presence of an open wound(s), and use of isolation precau-
tions. Clinical infection was defined as the presence of infection 
by physician documentation and receipt of oral or parenteral 
systemic antibiotics. At the time of study discharge, we docu-
mented the discharge disposition as (1) discharged home; (2) 
discharged to skilled nursing facility; (3) discharged to another 
unit; (4) discharged at the patient’s or family’s request; or (5) 
other disposition, including hospice care or leaving the hospital 
against medical advice. Both hospitals have comprehensive 
infection prevention programs (Supplementary Materials).
Microbiologic Methods
Trained research staff swabbed the palm, fingers, and around 
nails of the dominant hand of enrolled patients, as well as the 
interior of the nares of both nostrils [7]. Samples were also col-
lected from 6 high-touch surfaces in the patients’ rooms: (1) bed 
control/bed rail; (2) call button/television remote; (3) bedside 
tray table top; (4) phone; (5) toilet seat; and (6) bathroom door 
knob. If roommates were enrolled and cultured on the same day 
(n = 10 visits), the toilet seat and bathroom door knob samples 
were collected once. Hospital A personnel also obtained peri-
anal cultures from a subset of patients to correlate MDRO col-
onization with clinical cultures. Microbiological samples were 
collected at study enrollment (within 24 hours of the patient’s 
arrival to their room), day 3, day 7, and weekly until hospital 
discharge, at which time a discharge set of cultures was obtained 
when possible. Premoistened Culturette swabs (Remel, Lenexa, 
Kansas) were used to obtain the high-touch room surface sam-
ples, applying the swab to a 5- × 20-cm area of each site. All 
samples were tested using standard microbiological methods by 
the research team. Enrolled patients were not cohorted based 
on study findings.
Additionally, we were interested in uncovering whether 
MRSA strains on patient hands were related to those found 
in the patient’s room at the same visit. Thus, we performed 
molecular typing on patient hand and room surface MRSA iso-
lates from both hospitals using pulsed-field gel electrophoresis 
(PFGE) and polymerase chain reaction (PCR)–based typing 
(for additional details, see Supplementary Materials) [17–20].
Statistical Analyses
The main outcomes of interest were baseline prevalence and 
incidence rates of acquisition of MDROs on patients’ hands 
and on high-touch room surfaces. To assess MDRO pres-
ence on patient recruitment, data from all patients were used 
(n = 399; Supplementary Materials) [21, 22]. To estimate the 
incidence of MDRO acquisition during hospitalization, the 
analysis was limited to patients with at least 2 study visits 
(n = 225). To define new acquisition (per 1000 patient-days), 
we excluded patients colonized at baseline enrollment with 
that organism. For example, to define new MRSA acquisi-
tion, we excluded patients who were colonized with MRSA 
at enrollment. To define rates of new MDRO acquisition, we 
excluded patients colonized at enrollment with all 3 MDROs. 
At each patient or room surface site, we counted at-risk days 
from the baseline visit to the first visit in which we found 
a resistant pathogen or until the discharge visit. Data were 
analyzed using SAS version 9.4 (SAS Institute, Cary, North 
Carolina) and Stata version 13.0 (StataCorp, College Station, 
Texas) software.
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RESULTS
Baseline Characteristics
A total of 399 of 524 (76%) eligible patients were enrolled and 
followed for 710 visits (flowchart, Supplementary Figure 1). The 
baseline demographics of the patients are shown in Table 1. The 
mean age was 60.8 years (standard deviation, 16.8 years). Forty-
nine percent were male; 64.4% identified as white and 25.3% 
identified as African American. A majority (80.5%) of patients 
had at least 1 comorbidity at baseline and 25% were depen-
dent in at least 1 ADL. Baseline characteristics among patients 
dependent in at least 1 ADL vs patients completely indepen-
dent are shown in Supplementary Table 1. There were no deaths 
among our subjects during the study period.
Patient and Room Surface Contamination With MDRO at Enrollment
Fourteen percent (56/399) of patients were colonized with an 
MDRO at baseline. Ten percent (40/399) had an MDRO on their 
hands, 7.5% (30/399) in their nares, and 3.5% (14/399) on both. 
Among those colonized with an MDRO, 57% (32/56) harbored 
MRSA, 36% (20/56) RGNB, and 14% (8/56) VRE. Perianal cul-
tures were obtained from 41 patients at hospital A at the time 
of study enrollment; 7% (n = 3) of patients cultured at the peri-
anal area were positive for VRE and 7% (n = 3) were positive for 
RGNB. Of the 56 patients colonized with an MDRO at enroll-
ment, 11 (20%) had a history of MDRO colonization or infection 
(5 of whom were colonized with the same MDRO he or she had a 
reported history of—ie, 4 with MRSA, 1 with RGNB).
Twenty-nine percent (n  =  115) of the sampled surfaces of 
patient rooms were contaminated with an MDRO at baseline 
(Figure 1). Fifteen percent of these surfaces were contaminated 
with RGNB, 8.5% with MRSA, and 8% with VRE. Hospitals A and 
B varied with regard to the types of MDROs identified. The most 
prevalent MDROs at hospital A were VRE (11%, n = 22), followed 
by MRSA (8%) and RGNB (1.5%); the most prevalent MDROs 
at hospital B were RGNB (29%, n = 57), followed by MRSA (9%) 
and VRE (5%). See Supplementary Table 2 for the most common 
RGNBs found on enrolled patients and room surfaces.
Hand Carriage of MDROs at Enrollment and During Follow-up
At baseline, 10% of patients’ dominant hands were contami-
nated with an MDRO; 5% with MRSA, 3.5% with RGNB, and 
2% with VRE. Of the 5% (n = 20 patients) with MRSA contam-
ination on the hand, 10 (50%) were concurrently colonized at 
the nares. MRSA contamination at baseline remained persistent 
in 6 (30%) patients and transient in 14 (70%) patients. An 
additional 6.2% (n = 14) of 225 patients with a follow-up visit 
acquired a new MDRO on their hands (Figure 1). Of interest, 
we observed a stepwise increase in MDRO contamination in 
patients and room surfaces as the number of hours in the room 
prior to enrollment and baseline sampling increased (Figure 2).
We were particularly interested in correlation between clin-
ical infection and colonization with an MDRO on patients’ 
anatomic sites, in particular their dominant hands. Six study 
patients had an MRSA-positive clinical culture (3 wounds, 1 
blood, 1 urine, and 1 sputum) during the study. Of these, MRSA 
was detected either from the patient’s sample or the room sam-
ple 100% of the time (4/6 patient dominant hands, 2/6 patient 
nares, 1/6 patient hand and nares, 4/6 patient room). No VRE 
was detected in clinical cultures. Of the 84 total perianal cul-
tures collected from 42 patients at hospital A, no colonization 
results correlated with clinical culture results.
To estimate the patient acquisition rates of a new MDRO, the 
analysis included 225 patients with >1 study visit (148 at hos-
pital A, 77 at hospital B) (536 total sampling visits). At hospital 
A, 10.1% (n = 15/148) of patients acquired an MDRO during 
follow-up, for a rate of 29.0/1000 patient-days (Table 2). At hos-
pital B, 7.8% (n = 6/77) of patients acquired an MDRO during 
follow-up, for a rate of 17.8/1000 patient-days. The median time 
to new colonization with MRSA, VRE, or RGNB was 11, 7, and 
3 days, respectively (Supplementary Figure 2).
Similarity Between Patient Hand Contamination and Room Surface 
Contamination
The room surfaces of patients were contaminated with MRSA, 
RGNB, and VRE at 9.2%, 13.2%, and 9.7% of visits, respectively. 
Patient hands were colonized with MRSA at 5% of the sampling 
study visits, RGNB at 3.0%, and VRE at 2.5% of visits. In 10% 
(73/710) of sampling visits, patients and their room surfaces were 
concurrently colonized with an MDRO (ie, patient and environ-
ment samples were positive for the same MDRO on the same 
sampling visit). Hand contamination with MRSA and VRE were 
each associated with contamination of the patient’s high-touch 
room surfaces by the same organism (Table 3). For example, of 
35 visits where patient hands were colonized with MRSA, 71.4% 
of patient rooms were also contaminated with MRSA (Table 3). 
MRSA was not detected in the patient’s room in 94.1% of visits 
when MRSA was not found on hands (P < .001). To confirm this 
finding, we typed 118 MRSA isolates from all 25 visits where 
MRSA was recovered from both the patient’s dominant hand and 
at least 1 room surface at the same visit. At hospital A, all 15 vis-
its (n = 9 patients) showed matching MRSA strains (≥90% in 14 
visits, 86% in 1 visit using Dice criteria for PFGE and PCR typing 
[19]) between the hand sample and at least 1 environmental site. 
At hospital B, 9 of the 10 visits (n = 7 patients) showed match-
ing MRSA strains (100% similarity). One such case in which the 
same MRSA strain was on the patient and in the patient’s room 
is shown in Supplementary Figure 3. The single visit that did not 
show 100% similarity between MRSA strains included a USA300 
from both the patient hand and room surface at enrollment and 
a USA800 on the patient hand at a subsequent visit.
DISCUSSION
For more than a century, hand hygiene research, resources, and 
promotion have almost exclusively focused on improving HCP 
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Table 1. Baseline Characteristics of Patients
Characteristic
All Patients 
(N = 399)
Hospital A 
(n = 200)
Hospital B 
(n = 199)
Age, mean, y (SD) 60.8 (16.8) 58.7 (16.2) 63.0 (17.2)
Sex, male 195 (48.9) 98 (49.0) 97 (48.7)
Race    
 White 257 (64.4) 173 (86.5) 84 (42.2)
 African American 101 (25.3) 15 (7.5) 86 (43.2)
Admitted from    
 Home 385 (96.5) 188 (94.0) 190 (95.5)
 Urgent care/clinic 49 (12.3) 42 (21.0) 7 (3.5)
 ED transfer 16 (4.0) 15 (7.5) 1 (0.5)
 Outpatient 3 (0.8) 3 (1.5) 0 (0)
 Home healthcare service 1 (0.3) 0 (0) 1 (0.5)
 Nursing home/assisted living 13 (3.3) 11 (5.5) 9 (4.5)
 Homeless shelter 1 (0.3) 1 (0.5) 0 (0)
Days of study follow-up, mean (SD) 2.3 (3.0) 3.5 (3.8) 1.0 (0.1)
No. of study visits, mean (SD) 1.8 (0.9) 2.1 (0.9) 1.5 (0.7)
Reason for study discharge    
 Discharged home 322 (80.7) 152 (76.0) 170 (85.4)
 Discharged to subacute rehab/SNF 34 (8.5) 25 (12.5) 9 (4.5)
 Discharged to another unit 31 (7.8) 15 (7.5) 16 (8.0)
 At patient or family request 5 (1.3) 3 (1.5) 2 (1.0)
 Other (hospice or left AMA) 7 (1.8) 5 (2.5) 2 (1.0)
Shared room 229 (57.4) 137 (68.5) 92 (46.2)
History of MDRO (in past 90 d) 28 (7.0) 25 (12.5) 3 (1.5)
 MRSA 9 (2.3) 8 (4.0) 1 (0.5)
 RGNB 18 (4.5) 17 (8.5) 1 (0.5)
 VRE 4 (1.0) 3 (1.5) 1 (0.5)
Any comorbidity 321 (80.5) 167 (83.5) 154 (77.4)
ADL, No. (%) dependent    
 Bathing 76 (19.0) 55 (27.5) 21 (10.6)
 Dressing 70 (17.5) 50 (25.0) 20 (10.1)
 Toileting 61 (15.3) 43 (21.5) 18 (9.0)
 Transferring 89 (22.3) 66 (33.0) 23 (11.6)
 Continence 41 (10.3) 31 (15.5) 10 (5.0)
 Feeding 18 (4.5) 8 (4.0) 10 (5.0)
≥1 ADLs dependent 101 (25.3) 73 (36.5) 28 (14.1)
Present at enrollment:    
 Any infection 117 (29.3) 82 (41.0) 35 (17.6)
 SSTI 38 (9.5) 27 (13.5) 11 (5.5)
 UTI 26 (6.5) 20 (10.0) 6 (3.0)
 Pneumonia 26 (6.5) 20 (10.0) 6 (3.0)
 Antibiotic use 170 (42.6) 107 (53.5) 63 (31.7)
 Device use 68 (17.0) 46 (23.0) 22 (11.1)
 Urinary catheter 13 (3.3) 8 (4.0) 5 (2.5)
 Nephrostomy tube 2 (0.5) 1 (0.5) 1 (0.5)
 Feeding tube 12 (3.0) 9 (4.5) 3 (1.5)
 Central venous catheter 34 (8.5) 23 (11.5) 11 (5.5)
 Dialysis catheter 16 (4.0) 13 (6.5) 3 (1.5)
 Open wound(s) 51 (12.8) 37 (18.5) 14 (7.0)
 Contact precautions 36 (9.0) 32 (16.0) 4 (2.0)
Data are presented as no. (%) unless otherwise specified.
Abbreviations: ADL, activities of daily living; AMA, against medical advice; ED, emergency department; MDRO, multidrug-resistant organism; MRSA, methicillin-resistant Staphylococcus 
aureus; RGNB, resistant gram-negative bacteria; SD, standard deviation; SNF, skilled nursing facility; SSTI, skin and soft tissue infection; UTI, urinary tract infection; VRE, vancomycin-resistant 
enterococci.
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hand hygiene [23, 24]. These efforts have included efficient, 
safer, and more effective cleansing products, innovative educa-
tional delivery models, materials, and training, as well as audit-
ing strategies. With contemporary patients allotting substantial 
time toward interactions and procedures inside and outside their 
rooms, pathogen transfer between the environment and patient 
hands is likely and yet understudied. In this prospective cohort 
study, conducted in 2 different hospitals with diverse patient 
populations, we show that 10% of patient hands were colonized 
with an MDRO at enrollment, 29% of rooms were contaminated 
within 24 hours of admission, and patient hand contamination 
was associated with patient room contamination with the same 
MDRO. Furthermore, 6.2% of patient hands and 21.8% of rooms 
newly acquired an MDRO during the hospital stay.
Numerous studies show that on average, about 5% of HCP 
hands are contaminated with an MDRO [25–27], the most 
common being MRSA, VRE, and RGNB, such as Acinetobacter 
species and Pseudomonas aeruginosa [27]. Research on patient 
hand contamination by pathogens is now emerging [6, 7, 21, 
28–31]. Hedin and colleagues, using a fingerprinting method, 
showed that Escherichia coli, Klebsiella species, enterococci, 
and S.  aureus were commonly found on patient hands in a 
Swedish hospital during an outbreak with enteric pathogens 
[31]. Cao et al swabbed the dominant hands of 357 post–acute 
care patients newly admitted to nursing facilities and showed 
that 24% of this high-risk group had an MDRO on admission 
and an additional 10% acquired a new MDRO during their stay 
[7]. Cross-transmission with the environment was evident in 
a follow-up study showing that when post–acute care patients’ 
hands are culture-positive for an MDRO, their environment is 
often contaminated with the same MDRO [21, 28].
Our study advances this literature now in hospitals [32] by 
showing that the rates of patient hand contamination with an 
MDRO on admission to a hospital are high and new acquisition 
is frequent, perhaps surpassing that of HCP [25, 26]. In emerg-
ing healthcare systems where there is emphasis for early mobil-
ity, financial penalties for adverse events related to immobility 
and falls, and frequent treatment or procedures out of the room, 
patient hand contamination can have significant implications 
on MDRO transmission with both near and far environmental 
surfaces.
Furthermore, we show that one-third of the patient rooms 
were contaminated with an MDRO on the day of admission, 
with contamination evident in patients recruited within the first 
8 hours of room occupancy, suggesting that patients were often 
admitted with an MDRO and that there was a rapid change in 
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microbial milieu in patients’ rooms after admission. This was 
most pronounced in patients with a clinical culture that was 
positive for MRSA, where a majority of MRSA-infected patients 
also harbored MRSA on their hands. Future projects should 
explore how often patients come to the emergency room from 
the community with an MDRO, or any potential new MDRO 
acquisition by patients when being evaluated within our emer-
gency rooms or when receiving their diagnostic workup from 
the emergency room. We show that hand contamination with 
MRSA, VRE, and RGNB is associated with high-touch room 
surface contamination with the same organism, suggesting ac-
tive transmission with strain match approaching 100% between 
MRSA on patient hands and their room surfaces. Whether 
patient hand hygiene interventions and enhanced patient en-
gagement can reduce environmental contamination, MDRO 
transmission, and nosocomial infections merits further evalu-
ation [33–36]. Our observations suggest that at the minimum, 
patient hand hygiene programs should be targeted to MRSA-
infected patients as an additional infection prevention strategy.
We note a few limitations. First, although we recruited 
nearly 400 patients and conducted >700 visits, our sample is 
a fraction of all patients admitted to a hospital. Second, we 
obtained perianal cultures from a subset of patients to see if 
they predict clinical infection better than hand contamination. 
Future studies could obtain multianatomic site samples to fur-
ther explore this question. Third, we did not perform high-
touch surface cultures prior to room occupancy as recruitment 
occurred once patients were admitted to their rooms. Fourth, 
we cannot ascertain whether a patient contaminated the high-
touch room surfaces or whether pathogens were introduced by 
HCPs. Finally, our study does not address patient-to-patient 
transmission of pathogens, which remains a critical gap in 
MDRO transmission literature [37] and will be explored in 
subsequent projects. Although MRSA strains were deemed 
similar using both PFGE and PCR criteria, future studies 
should define the degree of similarity and timing of divergence 
using advanced genomic methods.
Limitations notwithstanding, our study also has strengths. 
First, this prospective cohort study was conducted in 2 dif-
ferent hospitals, serving very different and diverse populations. 
Second, we repeated the sampling over multiple follow-up visits 
from the same patients, allowing us to characterize new acqui-
sition rates at the patient level. Finally, we are the first to corre-
late patient hand contamination with high-touch room surface 
contamination in hospital settings using both traditional mi-
crobiologic and advanced molecular methods. This research 
is important to demonstrate similarity between patient hand 
and environmental contamination to then design future patient 
hand hygiene interventions that would reduce both.
While the burden of preventing infections has largely been 
borne by HCP, our study shows that patient hands are an 
important reservoir and play a crucial role in the transmission 
of pathogens in acute care hospitals. Thus, patient hand hygiene 
protocols should be implemented and tested for their ability 
to reduce environmental contamination, pathogen transmis-
sion, and healthcare-associated infections as well as to increase 
meaningful patient engagement in infection prevention.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online. 
Consisting of data provided by the authors to benefit the reader, the posted 
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